A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.
- Published In:
- Nature medicine, 31(12), 4246-4255 (2025)
- Authors:
- Baretti, Marina, Kirk, Allison M, Ladle, Brian H, Kamdar, Zeal, Bendinelli, Kayla J, Ho, Won Jin, Adhikari, Samir, Clark, Nicholas A, Sundararaman, Balaji, Wang, Hao, Kung, Heng-Chung, Hernandez, Jeric, Qi, Hanfei, Shin, Sarah M, Hernandez, Alexei, Nakazawa, Mari, Schattgen, Stefan A, Crawford, Jeremy Chase, Furth, Mark, Anders, Robert A, Thoburn, Chris, Zaidi, Neeha, Huff, Amanda L, Nauroth, Julie, Jaffee, Elizabeth, Pogorelyy, Mikhail V, Thomas, Paul G, Yarchoan, Mark
- Database ID:
- RPEP-10095
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10095APA
Baretti, Marina; Kirk, Allison M; Ladle, Brian H; Kamdar, Zeal; Bendinelli, Kayla J; Ho, Won Jin; Adhikari, Samir; Clark, Nicholas A; Sundararaman, Balaji; Wang, Hao; Kung, Heng-Chung; Hernandez, Jeric; Qi, Hanfei; Shin, Sarah M; Hernandez, Alexei; Nakazawa, Mari; Schattgen, Stefan A; Crawford, Jeremy Chase; Furth, Mark; Anders, Robert A; Thoburn, Chris; Zaidi, Neeha; Huff, Amanda L; Nauroth, Julie; Jaffee, Elizabeth; Pogorelyy, Mikhail V; Thomas, Paul G; Yarchoan, Mark. (2025). A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.. Nature medicine, 31(12), 4246-4255. https://doi.org/10.1038/s41591-025-03995-y
MLA
Baretti, Marina, et al. "A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.." Nature medicine, 2025. https://doi.org/10.1038/s41591-025-03995-y
RethinkPeptides
RethinkPeptides Research Database. "A therapeutic peptide vaccine for fibrolamellar hepatocellul..." RPEP-10095. Retrieved from https://rethinkpeptides.com/research/baretti-2025-a-therapeutic-peptide-vaccine
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.